JAZZ today
$240.37-$7.87 (-3.17%)close Nov 12, 2026Trend
DailyDowntrend (confirmed)
4 hourLeaning Bearish
1 hourStrong Bearish
15 minDescending Triangle
5 minConsolidating
Daily trend turns up above $216.43
Key levels
Resistance$256.92
Resistance$247.31
Support$238.87
Support$229.16
Latest news & SEC filings
AnalystJazz Pharmaceuticals gets higher target from Piper Sandler
AnalystPiper Sandler keeps Overweight on Jazz Pharmaceuticals, lifts target to $330
GuidanceJazz Pharmaceuticals lifts its 2026 revenue outlook
All JAZZ news →About Jazz Pharmaceuticals
Jazz Pharmaceuticals is a biopharmaceutical company that develops and sells medicines for rare diseases, including epilepsy, cancer, and sleep disorders. Its marketed treatments include Xywav and Xyrem for narcolepsy and idiopathic hypersomnia, Epidiolex for certain seizure conditions, and cancer therapies such as Zepzelca, Ziihera, and Rylaze. The company sells to patients, physicians, and healthcare providers, with operations in the United States, Europe, Canada, and other international markets.
Based on the company's 10-K filed Feb 24, 2026.
Nasdaq · Healthcare
Jazz Pharmaceuticals plc (JAZZ)
What Is the Price Target for JAZZ?
SEPT Low Target
$275.00
SEPT Mid Target
$302.50
SEPT High Target
$337.00
Analyst Consensus
$302.50
Is JAZZ a Buy or Sell Right Now?
Thesis
- •Revenue growing 4.9% YoY with STABLE trend — consistent growth.
- •SEC filings signal active product innovation — 2 new product/expansion keywords detected in 10-K. R&D investment stable.
AI-Powered Trading Signals
Trained on trillions of real market data to read price action and give you a simple, emotionless trading strategy for JAZZ.
Start Free Trial →Is JAZZ Overvalued or Undervalued?
Valuation Verdict
FAIR
Methods Used
P/E Forward, Analyst Consensus
Fair Value
$289.13
16
Moat Score
NONE
4/9
Piotroski Score
N/A
Altman Z-Score
What Is Smart Money Doing with JAZZ?
Insider Signal
SELLING
0 buys / 4 sells (90d)
Congress Signal
NEUTRAL
0 buys / 0 sells (90d)
Institutional
N/A
Short Squeeze Risk
LOW
Signal: NEUTRAL
Recent Insider Activity
| Name | Title | Type | Shares | Value | Date |
|---|---|---|---|---|---|
| COZADD BRUCE C | director | Buy | 734 | $100K | Nov 6, 2026 |
| COZADD BRUCE C | director | Buy | 85,766 | $11.7M | Nov 6, 2026 |
| COZADD BRUCE C | director | Sale | 27,714 | $6.5M | Nov 6, 2026 |
| COZADD BRUCE C | director | Sale | 10,688 | $2.5M | Nov 6, 2026 |
| COZADD BRUCE C | director | Sale | 24,483 | $5.8M | Nov 6, 2026 |
| COZADD BRUCE C | director | Sale | 5,923 | $1.4M | Nov 6, 2026 |
| Carr Patricia | officer | Buy | 1,250 | $175K | Nov 4, 2026 |
| Carr Patricia | officer | Sale | 1,250 | $289K | Nov 4, 2026 |
| Carr Patricia | officer | Sale | 163 | $38K | Nov 4, 2026 |
| GALA RENEE D | director officer | Sale | 1,000 | $225K | Nov 3, 2026 |
Track Smart Money Across 4,000+ Stocks
Insider trades, congress trades, institutional flows, and short interest — updated daily with real-time alerts.
See All Smart Money Signals →JAZZ Growth Story
Revenue YoY
4.9%
3yr Revenue CAGR
5.3%
EPS Growth YoY
-167.51%
FCF Growth YoY
-4.5%
Revenue Trend
STABLE
Dark Pool Trades for JAZZ
PREVIEWSEPT Investing tracks real-time dark pool institutional trades for JAZZ, including block trade sizes, dollar values, and buy/sell side classification. Dark pool trades reveal where institutional investors are positioning before moves become visible on public exchanges.
| Time | Price | Size | Value | Side |
|---|---|---|---|---|
| 21:00:32 | $240.37 | 2,749 | $$661K | BUY |
| 20:58:34 | $240.77 | 1,000 | $$241K | SELL |
| 15:43:07 | $246.03 | 1,700 | $$418K | BUY |
| 15:35:26 | $245.51 | 1,029 | $$253K | MIDPOINT |
| 15:16:25 | $244.34 | 1,492 | $$365K | BUY |
5 dark pool trades shown · $$1.9M preview volume
Real-time institutional flow, block trades, and net positioning
Options Flow for JAZZ
PREVIEWSEPT Investing provides real-time options flow tracking for JAZZ, including unusual sweep detection, block trades, and dealer positioning. Each trade shows strike, expiry, premium, implied volatility, and greek values for informed decision-making.
| Type | Strike | Expiry | DTE | Premium | Size | Trade |
|---|---|---|---|---|---|---|
| CALL | $210 | Jan 15 | 64 | $$498.8K | 133 | BLOCK |
1 options trades shown · 100% calls
Unusual activity, GEX levels, max pain, and dealer positioning
Full AI Research Report
SEPT's Trading AI has generated a free, downloadable PDF research report for Jazz Pharmaceuticals plc (JAZZ) covering valuation analysis, financial health assessment, growth projections, smart money tracking, earnings and key price levels. For research only, not investment advice.
Report includes: PDF download, detailed valuation models (DCF, P/E, EV/EBITDA), institutional flow analysis, congress and insider trade tracking, FinBERT news sentiment (5 articles analyzed), and SEC filing intelligence...
AI-Powered Trading Signals.
Trained on trillions of real market data to read price action and give you a simple, emotionless trading strategy. SEPT tells you when to buy, when to sell, and grades every stock so you never trade blind.
Try SEPT Free for 7 Days →JAZZ — frequently asked questions
What is JAZZ stock price today?
Jazz Pharmaceuticals plc (JAZZ) is at $240.37, down 3.17% (-$7.87) at the Nov 12, 2026 close.
Why is JAZZ stock moving today?
Latest JAZZ news — Nov 12, 2026: Jazz Pharmaceuticals gets higher target from Piper Sandler · Nov 12, 2026: Piper Sandler keeps Overweight on Jazz Pharmaceuticals, lifts target to $330
What is the JAZZ price target?
The average analyst price target for JAZZ is $302.50, ranging from $275 to $337, based on 14 analysts. Latest: Morgan Stanley maintains on Nov 3, 2026.
What do analysts rate JAZZ?
Analyst ratings for JAZZ: 1 Buy, 39 Hold, 0 Sell — consensus Hold.
Did JAZZ beat earnings?
JAZZ last reported on Nov 2, 2026: EPS -$3.88 vs -$4.05 expected — a beat of 4.2%.
Does JAZZ pay a dividend?
JAZZ does not currently pay a dividend.
How much debt does JAZZ have?
Jazz Pharmaceuticals plc reported $5.6B of debt and $2.0B of cash (Sep 30, 2026).
What are JAZZ support and resistance levels?
Support: $238.87, $229.16, $216.43. Resistance: $247.31, $256.92, $266.38.
What are insiders doing with JAZZ?
Insider activity: SELLING, 0 buys and 4 sells in the last 90 days.
What is the latest news on JAZZ?
Nov 12, 2026: Jazz Pharmaceuticals gets higher target from Piper Sandler · Nov 12, 2026: Piper Sandler keeps Overweight on Jazz Pharmaceuticals, lifts target to $330 · Nov 9, 2026: Jazz Pharmaceuticals lifts its 2026 revenue outlook